Shuttle Pharmaceuticals Files 8-K
Ticker: SHPH · Form: 8-K · Filed: Apr 10, 2025 · CIK: 1757499
| Field | Detail |
|---|---|
| Company | Shuttle Pharmaceuticals Holdings, Inc. (SHPH) |
| Form Type | 8-K |
| Filed Date | Apr 10, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, 8-k
TL;DR
Shuttle Pharma filed a routine 8-K, no major news yet.
AI Summary
Shuttle Pharmaceuticals Holdings, Inc. filed an 8-K on April 10, 2025, reporting "Other Events" and "Financial Statements and Exhibits." The filing does not contain specific details about new events, financial figures, or material changes, but serves as a standard regulatory update.
Why It Matters
This filing indicates Shuttle Pharmaceuticals is meeting its regulatory reporting obligations. Investors should review any attached exhibits for potential new information.
Risk Assessment
Risk Level: low — The filing is a standard procedural document without disclosed material events, indicating low immediate risk from this specific report.
Key Players & Entities
- Shuttle Pharmaceuticals Holdings, Inc. (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- April 10, 2025 (date) — Date of earliest event reported
FAQ
What specific "Other Events" are being reported by Shuttle Pharmaceuticals Holdings, Inc. in this 8-K filing?
The provided text of the 8-K filing does not specify the details of the "Other Events" beyond listing it as an item information category.
What "Financial Statements and Exhibits" are included with this 8-K filing?
The filing lists "Financial Statements and Exhibits" as an item information category, but the specific contents of these exhibits are not detailed in the provided text.
What is the principal executive office address for Shuttle Pharmaceuticals Holdings, Inc.?
The principal executive offices of Shuttle Pharmaceuticals Holdings, Inc. are located at 401 Professional Drive, Suite 260, Gaithersburg, MD 20879.
What is the telephone number for Shuttle Pharmaceuticals Holdings, Inc.?
The telephone number for Shuttle Pharmaceuticals Holdings, Inc. is (240) 430-4212.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on April 10, 2025.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 10, 2025 regarding Shuttle Pharmaceuticals Holdings, Inc. (SHPH).